Embrechts
Anika Embrechts, Pijnacker NL
Patent application number | Description | Published |
---|---|---|
20130245606 | HYDROGEL BASED OCCLUSION SYSTEMS - A hydrogel based occlusion system, a method for occluding vessels, appendages or aneurysms, and a method for hydrogel synthesis are disclosed. The hydrogel based occlusion system includes a hydrogel having a shrunken and a swollen state and a delivery tool configured to deliver the hydrogel to a target occlusion location. The hydrogel is configured to permanently occlude the target occlusion location in the swollen state. The hydrogel may be an electro-activated hydrogel (EAH) which could be electro-activated with a delivery system to control the degree of swelling/shrinking. | 09-19-2013 |
Hugo Embrechts, Bierbeek BE
Patent application number | Description | Published |
---|---|---|
20150365235 | METHOD, SYSTEM AND ELECTRONIC DEVICE - A method comprising generating an auxiliary key based on a secret key which is stored in an electronic device, generating a representation of the auxiliary key, displaying the representation of the auxiliary key on a display of the first electronic device, capturing the representation of the auxiliary key with a camera of a second electronic device, and restoring the auxiliary key from the captured representation of the auxiliary key. | 12-17-2015 |
Mark Embrechts, Clifton Park, NY US
Patent application number | Description | Published |
---|---|---|
20130178730 | Use of Machine Learning for Classification of Magneto Cardiograms - The use of machine learning for pattern recognition in magnetocardiography (MCG) that measures magnetic fields emitted by the electrophysiological activity of the heart is disclosed herein. Direct kernel methods are used to separate abnormal MCG heart patterns from normal ones. For unsupervised learning, Direct Kernel based Self-Organizing Maps are introduced. For supervised learning Direct Kernel Partial Least Squares and (Direct) Kernel Ridge Regression are used. These results are then compared with classical Support Vector Machines and Kernel Partial Least Squares. The hyper-parameters for these methods are tuned on a validation subset of the training data before testing. Also investigated is the most effective pre-processing, using local, vertical, horizontal and two-dimensional (global) Mahanalobis scaling, wavelet transforms, and variable selection by filtering. | 07-11-2013 |
20140343396 | Use of Machine Learning for Classification of Magneto Cardiograms - The use of machine learning for pattern recognition in magnetocardiography (MCG) that measures magnetic fields emitted by the electrophysiological activity of the heart is disclosed herein. Direct kernel methods are used to separate abnormal MCG heart patterns from normal ones. For unsupervised learning, Direct Kernel based Self-Organizing Maps are introduced. For supervised learning Direct Kernel Partial Least Squares and (Direct) Kernel Ridge Regression are used. These results are then compared with classical Support Vector Machines and Kernel Partial Least Squares. The hyper-parameters for these methods are tuned on a validation subset of the training data before testing. Also investigated is the most effective pre-processing, using local, vertical, horizontal and two-dimensional (global) Mahanalobis scaling, wavelet transforms, and variable selection by filtering. | 11-20-2014 |
Mark J. Embrechts, Clifton Park, NY US
Patent application number | Description | Published |
---|---|---|
20110047105 | Use of Machine Learning for Classification of Magneto Cardiograms - The use of machine learning for pattern recognition in magnetocardiography (MCG) that measures magnetic fields emitted by the electrophysiological activity of the heart is disclosed herein. Direct kernel methods are used to separate abnormal MCG heart patterns from normal ones. For unsupervised learning, Direct Kernel based Self-Organizing Maps are introduced. For supervised learning Direct Kernel Partial Least Squares and (Direct) Kernel Ridge Regression are used. These results are then compared with classical Support Vector Machines and Kernel Partial Least Squares. The hyper-parameters for these methods are tuned on a validation subset of the training data before testing. Also investigated is the most effective pre-processing, using local, vertical, horizontal and two-dimensional (global) Mahanalobis scaling, wavelet transforms, and variable selection by filtering. | 02-24-2011 |
Roger Embrechts, Beerse BE
Patent application number | Description | Published |
---|---|---|
20090111872 | STABILIZED PEDIATRIC SUSPENSION OF CARISBAMATE - The present invention provides a stabilized pharmaceutical suspension of carisbamate for pediatric and adult use. More particularly, the suspension is stabilized with hypromellose (HPMC) to prevent crystal growth of the suspended particles and to prevent re-crystallization of the drug product with change in polymorphic form. | 04-30-2009 |
20120309826 | STABILIZED PEDIATRIC SUSPENSION OF CARISBAMATE - The present invention provides a stabilized pharmaceutical suspension of carisbamate for pediatric and adult use. More particularly, the suspension is stabilized with hypromellose (HPMC) to prevent crystal growth of the suspended particles and to prevent re-crystallization of the drug product with change in polymorphic form. | 12-06-2012 |
Roger C.a Embrechts, Oud-Turnhout BE
Patent application number | Description | Published |
---|---|---|
20140274981 | PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE - The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative. | 09-18-2014 |
20140275276 | PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE - The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative. | 09-18-2014 |
20140275277 | PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE - The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative. | 09-18-2014 |
20140275278 | PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE - The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative. | 09-18-2014 |
Roger Carolus Augusta Embrechts, Turnhout BE
Patent application number | Description | Published |
---|---|---|
20120220630 | PRUCALOPRIDE ORAL SOLUTION - The present invention is concerned with an oral aqueous solution comprising prucalopride or pharmaceutically acceptable acid addition salts thereof having good organoleptic properties. | 08-30-2012 |
Roger Carolus Augusta Embrechts, Oud-Turnhout BE
Patent application number | Description | Published |
---|---|---|
20080234291 | Mitratapide Oral Solution - The present invention concerns an oral solution comprising the MTP inhibitor mitratapide or an pharmaceutically acceptable acid addition salt thereof, a process for preparing such solutions, and their use in the treatment of MTP-related disorders such as hyperlipidemia, obesity, or type II diabetes. | 09-25-2008 |
Roger Carolus Augusta Embrechts, Beerse BE
Patent application number | Description | Published |
---|---|---|
20120225950 | Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol - A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof. | 09-06-2012 |
20120225951 | Parenteral Administration of Tapentadol - An aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a pH value of at least 5.4. | 09-06-2012 |
20130022670 | Aqueous Pharmaceutical Formulation of Tapentadol for Oral Administration - An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability without relying on the presence of high amounts of preservatives. | 01-24-2013 |
Werner Embrechts, Beerse BE
Patent application number | Description | Published |
---|---|---|
20140045849 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS - This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as HCV or HBV. | 02-13-2014 |
20140073642 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES - This invention relates to quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy of disorders in which the modulation of toll-like-receptors is involved. | 03-13-2014 |
20140323441 | Purine derivatives for the treatment of viral infections - The present invention relates to purine derivatives of formula (I), processes for their preparation, pharmaceutical compositions, and their use in treating viral infections. | 10-30-2014 |
20150239892 | Pyrrolo[3,2-]pyrimidine derivatives for the treatment of viral infections and other diseases - This invention concerns pyrrolo[3,2-d]pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treatment and/or therapy of diseases. | 08-27-2015 |
20150274676 | ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES - This invention relates to acylaminopyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy. | 10-01-2015 |
20150284339 | HETEROCYCLIC SUBSTITUTED 2-AMINO QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS - This invention relates to heterocyclic substituted 2-amino-quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections. | 10-08-2015 |
Werner Constant John Embrechts, Beerse BE
Patent application number | Description | Published |
---|---|---|
20100152174 | MACROCYCLIC QUINAZOLE DERIVATIVES AND THEIR USE AS MTKI - The present invention concerns the compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein Z represents NH; Y represents —C | 06-17-2010 |